Journals / Türk Otorinolarengoloji Arşivi / 2016 / Cilt: 54 - Sayı: 3

Total Larenjektomi Sonrası Faringokütanöz Fistül: Radyoterapi, Yoğun Sigara Kullanımı ve Diğer Risk Faktörlerinin İncelenmesi

Pharyngocutaneous Fistula after Total Laryngectomy: Risk Factors with Emphasis on Previous Radiotherapy and Heavy Smoking

Pages
91–98
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After the exclusion of patients withhistory of free flap reconstruction, previous laryngealsurgery, and previous radiotherapy (RT) for other primarycancers, the risk factors for PCF were analyzedin 183 patients who were included in the study.Results: The overall incidence of PCF was 20.2%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this retrospective cohort study, weaimed to determine the incidence of pharyngocutaneousfistula (PCF) after total laryngectomy (TL) andto define the possible predictors for PCF formation.Methods: The medical records of 198 patients with laryngealsquamous cell carcinoma who underwent TLwere reviewed.
📊
Key Findings & Data:After the exclusion of patients withhistory of free flap reconstruction, previous laryngealsurgery, and previous radiotherapy (RT) for other primarycancers, the risk factors for PCF were analyzedin 183 patients who were included in the study.Results: The overall incidence of PCF was 20.2%.
💡
Conclusion & Impact:Preventable measuresshould be taken to decrease the incidence and persistenceof this complication of TL in the managementof patients with possible risk factors.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this retrospective cohort study, weaimed to determine the incidence of pharyngocutaneousfistula (PCF) after total laryngectomy (TL) andto define the possible predictors for PCF formation.Methods: The medical records of 198 patients with laryngealsquamous cell carcinoma who underwent TLwere reviewed. After the exclusion of patients withhistory of free flap reconstruction, previous laryngealsurgery, and previous radiotherapy (RT) for other primarycancers, the risk factors for PCF were analyzedin 183 patients who were included in the study.Results: The overall incidence of PCF was 20.2%. Ahistory of heavy smoking and previous RT were detectedas independent risk factors in both univariate(p=0.004 and p=0.007, respectively) and multivariate(p=0.005) analyses. Preoperative tracheotomy (PT)longer than 14 days was a risk factor for PCF amongpatients with PT in the univariate analysis (p=0.031).Overall three- and five-year survival rates were statisticallyindifferent between the PCF and non-PCFgroups (p>0.05). However, the overall five-year survivalrate was lesser in the persistent PCF group(47%) than in the non-persistent PCF group (83%)(p=0.038).Conclusion: Heavy smoking and previous RT are independentrisk factors for PCF, and the persistenceof PCF decreases survival rates. Preventable measuresshould be taken to decrease the incidence and persistenceof this complication of TL in the managementof patients with possible risk factors.

Özet

Amaç: Bu geriye dönük kohort çalışmasında, total larenjektomi (TL) sonrası faringokütanöz fistül (FKF) sıklığını bulmayı ve FKF oluşumu için olası risk faktörlerini tanımlamayı amaçladık. Yöntemler: Laringeal yassı hücreli karsinom tanılı, TL geçirmiş 198 hastanın tıbbi kayıtları incelendi. Serbest flep ile onarım, önceki laringeal cerrahi ve başka birincil kanser için önceki radyoterapi (RT) öyküsü olan hastalar dışlandıktan sonra, çalışmaya dahil edilen 183 hastada FKF risk faktörleri araş- tırıldı. Bulgular: Genel FKF sıklığı %20.2 idi. Ağır sigara içimi ve önceki RT öyküsü hem tek değişkenli analiz (sırasıyla, p=0.004 ve p=0.007), hem de çok değişkenli analizlerde (her ikisi için, p=0.005) bağımsız risk faktörleri olarak saptandı. Tek değişkenli analizlerde 14 günden uzun süreli ameliyat öncesi trakeotomi (AÖT) FKF için risk faktörü idi (p=0.031). Genel 3 ve 5-yıllık sağkalım oranları FKF ve FKF-olmayan gruplar arasında istatistiksel olarak farksızdı (p>0.05). Oysaki, genel 5-yıllık sağkalım oranları inatçı FKF grubunda (%47), inatçı olmayan-FKF grubuna göre (%83) daha azdı (p=0.038). Sonuç: Ağır sigara içimi ve önceki RT, FKF için bağımsız risk faktörleridir ve FKF'nin inatçılık göstermesi sağkalım oranlarını azaltmaktadır. Olası risk faktörleri olan hastaların tedavisinde, TL'nin bu sı- kıntılı komplikasyonunun hem sıklığını ve hem de inatçılık göstermesini azaltmak için tüm önlenebilir tedbirler alınmalıdır

🔖

Cite This Article

İKİZ, A. Ö., ASLIER, M., ASLIER, N. G. Y., DOĞAN, E. (2022). Total Larenjektomi Sonrası Faringokütanöz Fistül: Radyoterapi, Yoğun Sigara Kullanımı ve Diğer Risk Faktörlerinin İncelenmesi. Türk Otorinolarengoloji Arşivi, Cilt: 54 - Sayı: 3, 91–98. https://ajindex.com/articles/640261

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg 2006
  2. [CrossRef ] 2. Thawley SE. Complications of combined radiation therapy and surgery for carcinoma of the larynx and inferior hypopharynx. Laryngoscope 1981
  3. Dedivitis RA, Aires FT, Cernea CR, Brandão LG. Pharyngocutaneous fistula after total laryngectomy: A systematic review of risk factors. Head Neck 2015
  4. [CrossRef ] 4. Edge SB, Byrd DR, Compton CC, Fritz AG, Green FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer
  5. Benson EM, Hirata RM, Thompson CB, Ha PK, Fakhry C, Saunders JR, et al. Pharyngocutaneous fistula after total laryngectomy: a single-institution experience, 2001-2012. Am J Otolaryngol 2015
  6. [CrossRef ] 6. Boscolo-R P, De Cillis G, Marchiori C, Carpenè S, Da Mosto MC. Multivariate analysis of risk factors for pharyngocutaneous fistula after total laryngectomy. Eur Arch Otorhinolaryngol 2008
  7. [CrossRef ] 7. Mäkitie AA, Niemensivu R, Hero M, Keski-Säntti H, Bäck L, Kajanti M, et al. Pharyngocutaneous fistula following total laryngectomy: a single institution's 10-year experience. Eur Arch Otorhinolaryngol 2006
  8. [CrossRef ] 8. Smith TJ, Burrage KJ, Ganguly P, Kirby S, Drover C. Prevention of postlaryngectomy pharyngocutaneous fistula: the Memorial University experience. J Otolaryngol 2003
  9. [CrossRef ] 9. Powell JT. Vascular damage from smoking: Disease mechanisms at the arterial wall. Vasc Med 1998
  10. [CrossRef ] 10. McRobert J. Smoking and its effects on the healing process of chronic wounds. Br J Community Nurs 2013
  11. Suppl: S18, S20- 3. 11. Ejaz S, Lim CW. Impact of sidestream whole smoke solutions on the outcome of wound repair and related angiogenesis. Environ Toxicol Pharmacol 2006
  12. [CrossRef ] 12. Fiorini FR, Deganello A, Larotonda G, Mannelli G, Gallo O. Tobacco exposure and complications in conservative laryngeal surgery. Cancers (Basel) 2014
  13. [CrossRef ] 13. Tsou YA, Hua CH, Lin MH, Tseng HC, Tsai MH, Shaha A. Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharyngectomy and salvage laryngopharyngectomy for advanced hypopharyngeal cancer. Head Neck 2010
  14. [CrossRef ] 14. Galli J, De Corso E, Volante M, Almadori G, Paludetti G. Postlaryngectomy pharyngocutaneous fis